메뉴 건너뛰기




Volumn 139, Issue 17, 2019, Pages 1985-1987

Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects

Author keywords

cell transdifferentiation; heart failure; hematocrit; hypoxia; sodium potassium pump; sympathetic nervous system

Indexed keywords

CANAGLIFLOZIN; DAPAGLIFLOZIN; EMPAGLIFLOZIN; ERTUGLIFLOZIN; ERYTHROPOIETIN; HEMOGLOBIN; PLACEBO; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; EPO PROTEIN, HUMAN; GLUCOSE;

EID: 85065066308     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.118.038881     Document Type: Review
Times cited : (188)

References (5)
  • 1
    • 84880850027 scopus 로고    scopus 로고
    • Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
    • Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B, List J, Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 2013 159 853 862. doi: 10.1111/dom.12127
    • (2013) Diabetes Obes Metab , vol.159 , pp. 853-862
    • Lambers Heerspink, H.J.1    De Zeeuw, D.2    Wie, L.3    Leslie, B.4    List, J.5
  • 2
    • 84938613439 scopus 로고    scopus 로고
    • Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats
    • O'Neill J, Fasching A, Pihl L, Patinha D, Franzén S, Palm F, Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats. Am J Physiol Renal Physiol 2015 309 F227 F234. doi: 10.1152/ajprenal.00689.2014
    • (2015) Am J Physiol Renal Physiol , vol.309 , pp. F227-F234
    • O'Neill, J.1    Fasching, A.2    Pihl, L.3    Patinha, D.4    Franzén, S.5    Palm, F.6
  • 5
    • 85044531581 scopus 로고    scopus 로고
    • Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo-controlled, double-blind clinical trials
    • Sano M, Chen S, Imazeki H, Ochiai H, Seino Y, Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: subanalysis of placebo-controlled, double-blind clinical trials. J Diabetes Investig 2018 9 638 641. doi: 10.1111/jdi.12726
    • (2018) J Diabetes Investig , vol.9 , pp. 638-641
    • Sano, M.1    Chen, S.2    Imazeki, H.3    Ochiai, H.4    Seino, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.